itraconazole has been researched along with Paronychia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gunasekara, TA; Nagahawatte, A; Ranawaka, RR | 1 |
de Silva, SH; Ranawaka, RR | 1 |
Colombo, MD; Ghetti, E; Piraccini, BM; Tosti, A | 1 |
1 trial(s) available for itraconazole and Paronychia
Article | Year |
---|---|
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Methylprednisolone; Middle Aged; Naphthalenes; Paronychia; Probability; Terbinafine; Treatment Outcome | 2002 |
2 other study(ies) available for itraconazole and Paronychia
Article | Year |
---|---|
Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Topics: Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Recurrence; Terbinafine; Treatment Outcome | 2015 |
Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Detergents; Diabetes Complications; Eczema; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Hypertension; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Risk Factors; Soil; Terbinafine; Time-to-Treatment; Treatment Outcome; Water; Young Adult | 2017 |